Paul Damon & Associates »

Novartis shares owned by Paul Damon & Associates

Quarter-by-quarter ownership of Novartis (NVS) shares owned by Paul Damon & Associates from 13F filings

Historical chart of Paul Damon & Associates investment in Novartis

Tip: Access up to 7 years of quarterly data

All positions including Novartis held by Paul Damon & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novartis by Paul Damon & Associates

Quarter filed Position value Share count Share price at filing
2025-12-31 $233k 1.7k 137.87

More positions owned by Paul Damon & Associates

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)
Apple (AAPL)
Ishares Tr Core S&p Us Vlu (IUSV)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
First Tr Exchange-traded SHS (FVD)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Grw Etf (IWF)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
Microsoft Corporation (MSFT)

View all positions for Paul Damon & Associates

Top funds holding Novartis

Dodge & Cox
Dimensional Fund Advisors
PRIMECAP Management Company
Fisher Investments
Loomis, Sayles and
Franklin Resources
GQG Partners
BlackRock
Goldman Sachs Group
Susquehanna International
Northern Trust
Cullen Capital Management
Henderson Group
Raymond James Financial
Wells Fargo & Company

View all funds holding Novartis